AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy. Targeted cancer therapy represents a promising new cancer treatment, one which delivers drugs in specific carriers and interferes with the specific target molecules that play a critical role in tumour growth and progression. Exosomes expressing specific surface markers (among them CD81, CD63, […]